2022, Number 1
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)
Circulating tumor cells in a patient with clinical suspicious of multiple myeloma
Roque GW, Jaime FJC, Concepción FY, Pelegrín ÁK
Language: Spanish
References: 13
Page: 1-8
PDF size: 544.72 Kb.
ABSTRACT
Introduction:
The circulating tumor cells in peripheral blood, known as carcinocythemia is a rare and poorly documented phenomenon, that can be a challenge diagnosis.
Objectives:
To describe the most frequents causes of carcinocythemia, the diagnosis challenges that it represents and to contribute raising awareness of this entity.
Case presentation:
Female patient, 71-year-old who complained bone pain and skin pale. The peripheral blood smear showed big size cells mimicking plasma cells. The immunophenotype by flow cytometry suggested IgM isotype multiple myeloma. Breast ultrasound and thorax tomography showed a tumor in the left breast. The bone marrow biopsy immunohistochemical was compatible with adenocarcinoma of breast. The patient died short after before receive specific treatment.
Conclusions:
We present a patient with circulating tumor cells secondary to breast adenocarcinoma where the bone marrow biopsy immunohistochemical ruled out multiple myeloma diagnosis suspected by clinical, image studies, cell morphology and immunophenotype.
REFERENCES
Asworth T. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J. 1869;14:146-7.
Carey RW, Taft PD, Bennet JM, Kaufman S. Carcinocythemia (carcinoma cell leukemia): an acute leukemia-like picture due to metastatic carcinoma cells. Am J Med. 1976 Feb;60(2):273-8. DOI: https://10.1016/0002-9343(76)90437-x
Kobayashi M, Tashima T, Nagata K, Sakuramoto S, Osaki A, Ryosawa S. Colorectal and gastric metastases from lobular breast cancer that resembled superficial neoplastic lesions. Clin J Gastroenterol. 2021;14:103-8. DOI: https://doi.org/10.1007/s12328-020-01285-3
Trefzer U, Schlegel C, Sterry W. Fulminant intravascular disseminated malignant melanoma mimicking acute leukemia. Blood. 1999 Aug;94(4):1483-4.
Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, et al. Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clin Chem.2019 Marh;65(3):462-72. DOI: https://10.1373/clinchem.2018.297028
Ronen S, Kroft SH, Olteanu H, Hosking PR, Harington AM. Carcinocythemia: a rare entity become more common? A 3-year, single institution series of seven cases and literature review. Int J Lab Hematol. 2019 Feb;41(1):69-79. DOI: https://10.1111/ijlh.12924
Jain M, Gupta S, Sukla P, Srivastaka A, Grover RK. A case of carcinocythemia following breast carcinoma mimicking acute leukemia: a case report and review of literature. Indian J Med Sci. 2017 Jan-March;69(1):52-4 DOI: https://10.18203/ISSN.0019-5359.INDIANJMEDSCI20170493
Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cells biology. Genes Dev. 2017 Sep;31(18):1827-40. DOI: https://10.1101/gad.305805.117
Joyce JA, Fearon DT. T cell exclusion, immune privilege and the tumor microenvironment. Science. 2015 Apr;348(6230):74-80. DOI: https://10.1126/science.aaa6204
Vivien-Serony S, Mery E, Delord JP, Fillola G, Tkaczuk J, Voigt JJ, et al. Carcinocythemia as the single extensión of breast cancer: report of a case and review of the literature. Ann Oncol 2001 Jul; (7):1019-22. DOI: https://10.1023/a:1011184706281
Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G, et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res. 2012 Oct;18(20):5701-10. DOI: https://10.1158/1078-0432.CCR-12-1587
Johnsrud AJ, Pina-Oviedo S. Carcinocythemia (carcinoma cell leukemia). Blood. 2017 Nov 23;130(21):2357. DOI: https://doi.org/10.1182/blood-2017-08-799882
Barksdale B, Catherine P. CD138+carcinocythemia mimicking plasma cell leukemia by flow cytometry. Blood. 2020 Oct,136(14):1698. DOI: https://doi.org/10.1182/blood.2020005518
Full text